DR HORTON INC (DHI) Stock Analyst Ratings
USA - NYSE:DHI - US23331A1097 - Common Stock
137.3 USD
-0.23 (-0.17%)
ChartMill assigns a Buy % Consensus number of 68% to DHI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 168.6. This target is 22.79% above the current price.
DHI was analyzed by 26 analysts. The buy percentage consensus is at 68. So analysts seem to be have mildly positive about DHI.
In the previous month the buy percentage consensus was at a similar level.
DHI was analyzed by 26 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-29 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2025-10-29 | UBS | Maintains | Buy -> Buy |
| 2025-10-29 | RBC Capital | Maintains | Underperform -> Underperform |
| 2025-10-29 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-10-10 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-10-07 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2025-10-01 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-09-18 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-09-02 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-07-24 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2025-07-23 | UBS | Maintains | Buy -> Buy |
| 2025-07-23 | RBC Capital | Maintains | Underperform -> Underperform |
| 2025-07-23 | Wedbush | Maintains | Neutral -> Neutral |
| 2025-07-23 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-04-22 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2025-04-21 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-04-21 | RBC Capital | Maintains | Underperform -> Underperform |
| 2025-04-21 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-21 | JP Morgan | Maintains | Underweight -> Underweight |
| 2025-04-14 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-04-08 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-03-06 | Seaport Global | Upgrade | Neutral -> Buy |
| 2025-01-22 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-01-22 | RBC Capital | Reiterate | Underperform -> Underperform |
| 2025-01-22 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-01-16 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-01-14 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-01-08 | UBS | Maintains | Buy -> Buy |
| 2025-01-06 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-12-17 | Wells Fargo | Maintains | Overweight -> Overweight |
DR HORTON INC / DHI FAQ
What is the price target for DHI stock?
26 analysts have analysed DHI and the average price target is 168.6 USD. This implies a price increase of 22.79% is expected in the next year compared to the current price of 137.3.
What is the consensus rating for DR HORTON INC (DHI) stock?
The consensus rating for DR HORTON INC (DHI) is 67.6923 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
How many analysts have analysed DR HORTON INC (DHI)?
The number of analysts covering DR HORTON INC (DHI) is 26.